[Intravenous trinitroglycerin in the treatment of pre-infarction syndrome. Preliminary results (author's transl)].
Intravenous trinitroglycerine (IV TNT) was used in 17 patients with myocardial pre-infarction syndrome defined by the presence of prolonged spontaneous attacks of attacks of angina, with electrocardiographic changes, persisting despite medical treatment with beta-blockers and oral nitrite derivatives. Seven patients had chronic angina, 7 had angina of recent onset and 3 patients had early post-infarction angina. IV TNT was used for 3 to 11 days at a mean dose of 40 micrograms/mn in 11 patients and 8 micrograms/mn in 6 patients. In the latter, cardiac output and pulmonary pressures were measured. IV TNT made it possible to decrease or stop angina attacks in all the patients except one. There was no significant variation in heart rate and mean blood pressure fell by 8 mmHg (p < 0.001). Cardiac index was maintained despite a fall in capillary pressure of 4.1 mmHg (p < 0.01). Coronary arteriography was performed in 16 cases, with circulatory assistance in 4 patients. Thirteen patients were treated by surgical revascularisation, with two operative deaths. IV TNT appeared to be effective and well tolerated treatment in these particularly severe forms of unstable angina.
D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D009202:Cardiomyopathies / Q000188:drug therapy*; D004351:Drug Resistance; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin / Q000494:pharmacology / Q000627:therapeutic use*; D013577:Syndrome
D005996:Nitroglycerin
La trinitrine intraveineuse dans le traitement du syndrome de menace. Résultats préliminaires.